|
Orthologous residues
|
|
c‑Raf (human): S233‑p, c‑Raf (mouse): S233‑p, c‑Raf (rat): S233‑p, c‑Raf (chicken): S233‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phosphopeptide mapping
|
|
Relevant cell lines - cell types - tissues:
3T3 (fibroblast) [SHP-2 (mouse), homozygous knockout], COS (fibroblast)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
monkey, mouse
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
EGF
|
|
|
|
decrease
|
|
|
forskolin, IBMX
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
14-3-3 beta (human)
|
|
Induces
|
|
|
co-immunoprecipitation
|
|
HRas (human)
|
|
Disrupts
|
|
|
co-immunoprecipitation
|
|